About NCE Grid
Welcome to the NCE Grid
Your Go-To Platform for Tracking NCE-1 Drug Filings
Stay ahead in generic drug development with the NCE Grid. It is a powerful platform designed to help you monitor, analyze, and stay tuned to the real-time filing information about the latest New Chemical Entity Minus 1 (NCE-1) filings.
What is NCE-1?
An NCE-1 filing, also known as a Paragraph IV filing, is a strategic submission to the U.S. FDA for a drug one step away from an already approved New Chemical Entity (NCE). These slight variations of the NCE-1 entities allow the generic price-friendly copies of the approved NCE to be brought to the market faster.
Why use NCE Grid?
Real-Time Alerts
Stay updated on the latest NCE-1 filings
Comprehensive Database
Access detailed insights on the current NCE-1 filings.
Competitive Intelligence
Track market trends, leading players, and projected sales impact.
Accelerate Your Market Access
The NCE Grid helps you streamline regulatory planning, gain strategic insights, and make faster, more informed decisions — all through a single, easy-to-use dashboard.
Contact Us for more details.
